0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Chondroitin for Pain in Osteoarthritis

David T. Felson, MD, MPH
[+] Article and Author Information

From Boston University and Boston Medical Center, Boston, Massachusetts.


Grant Support: Dr. Felson is supported by National Institutes of Health grant AR 47785.

Potential Financial Conflicts of Interest: Grants received: Merck & Co.

Requests for Single Reprints: David T. Felson, MD, MPH, Clinical Epidemiology, A203, Boston University School of Medicine, 80 East Concord Street, Boston, MA 02118; e-mail, jendez@bu.edu.


Ann Intern Med. 2007;146(8):611-612. doi:10.7326/0003-4819-146-8-200704170-00014
Text Size: A A A

Frequent knee pain affects about 25% of adults (1), at least half of whom have osteoarthritis (2). Persons with knee and other joint pain often take over-the-counter nutritional supplements available in grocery stores, in drug stores, or online for treatment of their joint pain. The most popular supplement is a pill containing a combination of glucosamine and chondroitin. The demand for the chondroitin component of this pill alone constitutes a $1 billion-per-year market in the United States.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Glucosamine sulfate, never hydrochloride
Posted on April 16, 2007
Patrick H. MacAuley
n.a,
Conflict of Interest: None Declared

Interesting editorial, but I have to comment on your statement that Glucosamine hydrochloride is the form of glucosamine most commonly used in America. The reality is that nearly all knowledgable users of stand-alone glucosamine will take Glucosamine sulfate, and only cheap products marketed to under-informed consumers will contain the hydrochloride form.

There are at least two theoretical reasons why the sulfate form should be superior: First, in some large joints glucosamine-sulfate-based compounds appear to serve as lubricants. Second, since glucosamine and sulphur are two of the most important constituents of cartilage, it would clearly seem better to take the the sulphur-containing form. (Some manufacturers claim that that it's OK to take the hydrochloride form if it's combined with Chrondoitin sulfate, but I'm skeptical, especially since so little Chondroitin sulfate is absorbed into the bloodtream.)

So even if you are correct that the hydrochloride form is more commonly used, it is used by less knowledgable users rather than serious students of nutrients. Of course, if they are getting a placebo effect from Glucosamine hydrochloride, it is fairly cheap and it doesn't appear to do any harm.

Conflict of Interest:

None declared

Chondroitin use contributes to global decline in shark populations
Posted on April 23, 2007
Martin T Donohoe
Portland State University
Conflict of Interest: None Declared

Shark cartilage serves as a major source of chondroitin.(1) The UN Food and Agricultural Organization reports that 70-80% of the world's shark fisheries are fully- to over-exploited, depleted, or in a state of collapse. (2) In the US, one of the few countries that even somewhat effectively manages any of its fisheries, the number of some species of coastal sharks has been reduced by 75-85% over the past 20 years.(2) Sharks are caught for their fins (to be used in soup), their cartilage (to be used in supplements), and their meat, as well as "inadvertently" through the use of long-line fishing. The United Nations Food and Agriculture Organization estimates that 100 million sharks, rays, and skates are fished yearly, but acknowledges that this number is too low, due to under-reporting by many of the 125+ nations engaged in the shark trade.(2) Unregulated fisheries in other countries and in international waters support a thriving, worldwide gray-market trade in shark skeletons.(2)

Shark cartilage first achieved widespread recognition through I. William Lane, whose 1992 bestseller Sharks Don't Get Cancer was promoted by a 1993 broadcast of 60 Minutes.(3) [Ironically, sharks do get cancers, including those of the cartilage.] A few years ago, the FDA took legal action to stop sales of BeneFin (one brand of shark cartilage) and two other alternative remedies produced by labs owned by Lane, claiming that such products may not be promoted and marketed as therapies until their efficacy has been proven.(3)

Nevertheless, some companies today market shark cartilage as pet neutraceuticals (e.g., Sea Pet Shark Cartilage Frosted Treats, "to enhance [your dog's] healthy joints", available at www.seapet.com).

Despite its lack of proven efficacy, Felson sees "no harm in encouraging patients to continue taking [chondroitin] as long as they perceive a benefit.(4) I disagree. In the midst of the largest global extinction since the demise of the dinosaurs 65 million years ago, when we are losing over 5,000 species per year (10,000 times the naturally- occurring rate of extinction), we must take special care to preserve all creatures and promote biodiversity.(5) Given that many currently available pharmaceutical and "neutraceutical" products are derived from or patterned after molecules found in plant and animal species, we must balance a respect for human, plant, and animal life and assure that a continuing source of effective organismal products are available for patients.

References:

1) Arthritis Foundation. Alternative therapies: glucosamine and chondroitin sulfate. Available at http://www.arthritis.org/conditions/alttherapies/glucosamine.asp. Accessed 4/20/07.

2) Kemper S. Shark. Smithsonian 2005 (August):43-51.

3) Rivlin, MA. Bad to the bone. The Amicus Journal (Natural Resources Defense Council) 2000(Spring):12-18.

4) Felson DT. Chondroitin for pain in osteoarthritis. Ann Int Med 2007;146:611-12.

5) Donohoe MT. Causes and health consequences of environmental degradation and social injustice. Soc Sci and Med 2003;56(3):573-587.

Conflict of Interest:

None declared

Chondroitin for Pain in Osteoarthritis
Posted on May 2, 2007
Guido Rovetta
Università di Genova
Conflict of Interest: None Declared

Dear Sir,

in his editorial article in Annals of Internal Medicine (Chondroitin for pain in osteoarthritis, 2007 Apr 17;146(8):611-2) dr. David T. Felson states "At least 1 trial reported that chondroitin was more effective than total knee replacement (6), a finding that lacks credibility (6. Rovetta G. Galactosaminoglycuronoglycan sulfate (matrix) in therapy of tibiofibular osteoarthritis of the knee. Drugs Exp Clin Res. 1991;17:53-7. [PMID: 1914837]). I think that dr. Felson must properly read my paper before quoting it. This sentence is completely invented.

With best regards

Prof. Guido Rovetta Università di Genova

Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)